Wize Pharma Fundamental Relationships

WIZP -- Israel Stock  

ILS 213.00  10.20  5.03%

The Drivers Module shows relationships between Wize Pharma's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Wize Pharma over time as well as its relative position and ranking within its peers. See also Your Current Watchlist.

Wize Pharma Cash Flow from Operations vs. Return On Asset Fundamental Analysis

Wize Pharma is rated below average in return on asset category among related companies. It is rated below average in cash flow from operations category among related companies .
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Wize Pharma 
Return on Asset 
 = 
Net Income 
Total Assets 
X
100 
=
(80.74) %
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.
Wize Pharma 
Operating Cash Flow 
 = 
EBITDA 
-  
Taxes 
=
(1.1 M)
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about company having enough liquid resources to meet current and long term debt obligations.

Wize Pharma Cash Flow from Operations Comparison

  Cash Flow from Operations 
      Wize Pharma Comparables 
Wize Pharma is currently under evaluation in cash flow from operations category among related companies.
  Revenue 
      Wize Pharma Comparables 
Wize Pharma is currently under evaluation in revenue category among related companies.
Search macroaxis.com